NCT07053605 Clinical Study on Laparoscopic Resection of Splenic Artery Aneurysm With Preservation of Spleen
| NCT ID | NCT07053605 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northern Jiangsu People's Hospital |
| Condition | Splenic Artery Aneurysm |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2025-06-23 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2025-06-23 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study, researchers examined the changes in related indicators such as immune function, splenic vein,proper hepatic artery, and portal venous hemodynamics following laparoscopic resection of a splenic artery aneurysm. We determined the changes in these patient-related indicators after surgical treatment and whether these changes could improve patient outcomes.
Eligibility Criteria
Inclusion Criteria: * Asymptomatic splenic artery aneurysms with a diameter\>2 cm,ruptured splenic artery aneurysms,and splenic artery aneurysms with a diameter increase\>0.5 cm/year. Aneurysm located in the main trunk of the splenic artery. Informed consent to participate in the study. Exclusion Criteria: * Patients with malignancies Hepatic cirrhosis with portal hypertension peptic ulcer disease Recent peptic ulcer disease History of Hemorrhagic stroke Pregnancy hematological diseases Uncontrolled Hypertension Human immunodeficiency virus (HIV) infection
Contact & Investigator
Guo-Qing Jiang
STUDY CHAIR
Clinical Medical College, Yangzhou University
Frequently Asked Questions
Who can join the NCT07053605 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Splenic Artery Aneurysm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07053605 currently recruiting?
Yes, NCT07053605 is actively recruiting participants. Contact the research team at jgqing2003@hotmail.com for enrollment information.
Where is the NCT07053605 trial being conducted?
This trial is being conducted at Yangzhou, China.
Who is sponsoring the NCT07053605 clinical trial?
NCT07053605 is sponsored by Northern Jiangsu People's Hospital. The principal investigator is Guo-Qing Jiang at Clinical Medical College, Yangzhou University. The trial plans to enroll 10 participants.